Julia Harris

Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension

Nazzareno Galiè, Joan Albert Barberà, Adaani Frost et al. · New England Journal of Medicine · 2015 · 1.2K citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +14

Once-daily dolutegravir versus darunavir plus ritonavir in antiretroviral-naive adults with HIV-1 infection (FLAMINGO): 48 week results from the randomised open-label phase 3b study

Bonaventura Clotet, Judith Feinberg, Jan van Lunzen et al. · The Lancet · 2014 · 501 citations

Pharmacy, Infectious Diseases, Pharmacokinetics +12

Initial combination therapy with ambrisentan and tadalafil in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH): subgroup analysis from the AMBITION trial

Gerry Coghlan, Nazzareno Galiè, Joan Albert Barberà et al. · Annals of the Rheumatic Diseases · 2016 · 181 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15

Disruption of the Cx43/miR21 pathway leads to osteocyte apoptosis and increased osteoclastogenesis with aging

Hannah M. Davis, Rafael Pacheco‐Costa, Emily G. Atkinson et al. · Aging Cell · 2017 · 145 citations · Full text

Life Sciences, Cell Biology, Apoptosis +16

Irbesartan in Marfan syndrome (AIMS): a double-blind, placebo-controlled randomised trial

Michael Mullen, Xu Yu Jin, Anne H. Child et al. · The Lancet · 2019 · 133 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17